Evidence map›Paper›PMID 25188023›Full record

ArticlePloS one2014

Systematic production of inactivating and non-inactivating suppressor mutations at the relA locus that compensate the detrimental effects of complete spot loss and affect glycogen content in Escherichia coli.

Manuel Montero, Mehdi Rahimpour, Alejandro M Viale, Goizeder Almagro, Gustavo Eydallin, Ángel Sevilla, Manuel Cánovas, Cristina Bernal, Ana Belén Lozano, Francisco José Muñoz and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Adaptive laboratory evolution ofFrontiers in microbiology · 2026
    Article
  2. Broad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Persisters-as elusive as ever.Applied microbiology and biotechnology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Manuel MonteroInstituto de Agrobiotecnología, UPNA/CSIC/Gobierno de Navarra, Mutiloabeti, Nafarroa, Spain.
Mehdi RahimpourInstituto de Agrobiotecnología, UPNA/CSIC/Gobierno de Navarra, Mutiloabeti, Nafarroa, Spain.
Alejandro M VialeInstituto de Agrobiotecnología, UPNA/CSIC/Gobierno de Navarra, Mutiloabeti, Nafarroa, Spain; Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET), Departamento de Microbiología, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina.
Goizeder AlmagroInstituto de Agrobiotecnología, UPNA/CSIC/Gobierno de Navarra, Mutiloabeti, Nafarroa, Spain.
Gustavo EydallinInstituto de Agrobiotecnología, UPNA/CSIC/Gobierno de Navarra, Mutiloabeti, Nafarroa, Spain.
Ángel SevillaDepartamento de Bioquímica y Biología Molecular e Inmunología, Facultad de Química, Campus de Excelencia Internacional Regional "Campus Mare Nostrum", Universidad de Murcia, Murcia, Spain.
Manuel CánovasDepartamento de Bioquímica y Biología Molecular e Inmunología, Facultad de Química, Campus de Excelencia Internacional Regional "Campus Mare Nostrum", Universidad de Murcia, Murcia, Spain.
Cristina BernalDepartamento de Bioquímica y Biología Molecular e Inmunología, Facultad de Química, Campus de Excelencia Internacional Regional "Campus Mare Nostrum", Universidad de Murcia, Murcia, Spain.
Ana Belén LozanoDepartamento de Bioquímica y Biología Molecular e Inmunología, Facultad de Química, Campus de Excelencia Internacional Regional "Campus Mare Nostrum", Universidad de Murcia, Murcia, Spain.
Francisco José MuñozInstituto de Agrobiotecnología, UPNA/CSIC/Gobierno de Navarra, Mutiloabeti, Nafarroa, Spain.
Edurne Baroja-FernándezInstituto de Agrobiotecnología, UPNA/CSIC/Gobierno de Navarra, Mutiloabeti, Nafarroa, Spain.
Abdellatif BahajiInstituto de Agrobiotecnología, UPNA/CSIC/Gobierno de Navarra, Mutiloabeti, Nafarroa, Spain.
Hirotada MoriGraduate School of Biological Sciences, Nara Institute of Science and Technology, Nara, Japan.
Francisco M CodoñerLifesequencing S.L., Paterna, Valencia, Spain.
Javier Pozueta-RomeroInstituto de Agrobiotecnología, UPNA/CSIC/Gobierno de Navarra, Mutiloabeti, Nafarroa, Spain.
Agrobiotechnology Institute · ESUniversidad de Murcia · ESGobierno de Navarra · ESInstituto de Biología Molecular y Celular de Rosario · ARNara Institute of Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Escherichia coli, ppGpp is a major determinant of growth and glycogen accumulation. Levels of this signaling nucleotide are controlled by the balanced activities of the ppGpp RelA synthetase and the dual-function hydrolase/synthetase SpoT. Here we report the construction of spoT null (ΔspoT) mutants obtained by transducing a ΔspoT allele from ΔrelAΔspoT double mutants into relA+ cells. Iodine staining of randomly selected transductants cultured on a rich complex medium revealed differences in glycogen content among them. Sequence and biochemical analyses of 8 ΔspoT clones displaying glycogen-deficient phenotypes revealed different inactivating mutations in relA and no detectable ppGpp when cells were cultured on a rich complex medium. Remarkably, although the co-existence of ΔspoT with relA proficient alleles has generally been considered synthetically lethal, we found that 11 ΔspoT clones displaying high glycogen phenotypes possessed relA mutant alleles with non-inactivating mutations that encoded stable RelA proteins and ppGpp contents reaching 45-85% of those of wild type cells. None of the ΔspoT clones, however, could grow on M9-glucose minimal medium. Both Sanger sequencing of specific genes and high-throughput genome sequencing of the ΔspoT clones revealed that suppressor mutations were restricted to the relA locus. The overall results (a) defined in around 4 nmoles ppGpp/g dry weight the threshold cellular levels that suffice to trigger net glycogen accumulation, (b) showed that mutations in relA, but not necessarily inactivating mutations, can be selected to compensate total SpoT function(s) loss, and (c) provided useful tools for studies of the in vivo regulation of E. coli RelA ppGpp synthetase.

Indexed as

Gene Expression Regulation, BacterialSuppression, GeneticAllelesAmino Acid SequenceClone CellsEscherichia coliGenetic LociGenotypeGlycogenLigasesMolecular Sequence DataPhenotypePyrophosphatasesSequence AlignmentTransduction, GeneticGlycogenguanosine-3',5'-bis(diphosphate) 3'-pyrophosphataseguanosine 3',5'-polyphosphate synthetasesLigasesPyrophosphatases

Identifiers

PMID25188023
PMCPMC4154780
OpenAlexW2056615937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.